Thermo Fisher Scientific Common Stock Net 2010-2025 | TMO
Thermo Fisher Scientific common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
- Thermo Fisher Scientific common stock net for the quarter ending March 31, 2025 was $444M, a 0.23% increase year-over-year.
- Thermo Fisher Scientific common stock net for 2024 was $0.444B, a 0.45% increase from 2023.
- Thermo Fisher Scientific common stock net for 2023 was $0.442B, a 0.23% increase from 2022.
- Thermo Fisher Scientific common stock net for 2022 was $0.441B, a 0.46% increase from 2021.
| Thermo Fisher Scientific Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $444 |
| 2023 | $442 |
| 2022 | $441 |
| 2021 | $439 |
| 2020 | $437 |
| 2019 | $434 |
| 2018 | $432 |
| 2017 | $428 |
| 2016 | $415 |
| 2015 | $412 |
| 2014 | $409 |
| 2013 | $370 |
| 2012 | $414 |
| 2011 | $406 |
| 2010 | $402 |
| 2009 | $424 |
| Thermo Fisher Scientific Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $444 |
| 2024-12-31 | $444 |
| 2024-09-30 | $444 |
| 2024-06-30 | $443 |
| 2024-03-31 | $443 |
| 2023-12-31 | $442 |
| 2023-09-30 | $442 |
| 2023-06-30 | $441 |
| 2023-03-31 | $441 |
| 2022-12-31 | $441 |
| 2022-09-30 | $440 |
| 2022-06-30 | $440 |
| 2022-03-31 | $440 |
| 2021-12-31 | $439 |
| 2021-09-30 | $439 |
| 2021-06-30 | $438 |
| 2021-03-31 | $438 |
| 2020-12-31 | $437 |
| 2020-09-30 | $437 |
| 2020-06-30 | $436 |
| 2020-03-31 | $435 |
| 2019-12-31 | $434 |
| 2019-09-30 | $434 |
| 2019-06-30 | $433 |
| 2019-03-31 | $433 |
| 2018-12-31 | $432 |
| 2018-09-30 | $431 |
| 2018-06-30 | $430 |
| 2018-03-31 | $429 |
| 2017-12-31 | $428 |
| 2017-09-30 | $428 |
| 2017-06-30 | $417 |
| 2017-03-31 | $416 |
| 2016-12-31 | $415 |
| 2016-09-30 | $415 |
| 2016-06-30 | $414 |
| 2016-03-31 | $413 |
| 2015-12-31 | $412 |
| 2015-09-30 | $411 |
| 2015-06-30 | $411 |
| 2015-03-31 | $410 |
| 2014-12-31 | $409 |
| 2014-09-30 | $408 |
| 2014-06-30 | $407 |
| 2014-03-31 | $407 |
| 2013-12-31 | $370 |
| 2013-09-30 | $419 |
| 2013-06-30 | $418 |
| 2013-03-31 | $417 |
| 2012-12-31 | $414 |
| 2012-09-30 | $411 |
| 2012-06-30 | $409 |
| 2012-03-31 | $409 |
| 2011-12-31 | $406 |
| 2011-09-30 | $406 |
| 2011-06-30 | $406 |
| 2011-03-31 | $403 |
| 2010-12-31 | $402 |
| 2010-09-30 | $426 |
| 2010-06-30 | $426 |
| 2010-03-31 | $425 |
| 2009-12-31 | $424 |
| 2009-09-30 | $423 |
| 2009-06-30 | $423 |
| 2009-03-31 | $422 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $151.802B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.994B | 86.72 |
| Edwards Lifesciences (EW) | United States | $44.969B | 29.49 |
| Alcon (ALC) | Switzerland | $42.113B | 28.46 |
| IDEXX Laboratories (IDXX) | United States | $41.363B | 47.53 |
| DexCom (DXCM) | United States | $34.106B | 52.72 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Mettler-Toledo (MTD) | United States | $24.056B | 28.61 |
| IQVIA Holdings (IQV) | United States | $24.009B | 13.45 |
| Waters (WAT) | United States | $21.101B | 29.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.538B | 0.00 |
| Hologic (HOLX) | United States | $14.197B | 15.43 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $10.235B | 80.33 |
| Masimo (MASI) | United States | $8.405B | 31.00 |
| Globus Medical (GMED) | United States | $8.016B | 19.10 |
| Glaukos (GKOS) | United States | $5.426B | 0.00 |
| Teleflex (TFX) | United States | $5.351B | 8.83 |
| TransMedics (TMDX) | United States | $4.350B | 94.57 |
| Integer Holdings (ITGR) | United States | $4.166B | 21.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.333B | 13.89 |
| Nihon Kohden (NHNKY) | Japan | $2.223B | 25.49 |
| Veracyte (VCYT) | United States | $2.093B | 29.36 |
| Elekta AB (EKTAY) | Sweden | $2.075B | 18.66 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.409B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.04 |
| Pulse Biosciences (PLSE) | United States | $1.206B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.987B | 5.25 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.657B | 33.33 |
| RxSight (RXST) | United States | $0.654B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.575B | 8.94 |
| Delcath Systems (DCTH) | United States | $0.564B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.560B | 13.18 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.461B | 12.26 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| NeuroPace (NPCE) | United States | $0.409B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.187B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.40 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.71 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |